FDA AI sample finder for Zeiss AXIO inverted microscope

The Food and Drug Administration Office of Acquisition and Grant Services seeks an AI Sample Finder system for an existing Zeiss AXIO Observer Z1 inverted fluorescence motorized microscope to support lot release testing of FluMist influenza vaccine, with quotes due July 2, 2026 at 2:00 pm CDT. No set-aside applies; any business size may submit.

Place of performance is the FDA CBER LBVI facility in Silver Spring, Maryland. The requirement is for a Zeiss "or equal" AI Sample Finder with specified sub-components: Camera Axiocam 305 mono R2, C-mount adapter 60N C 2/3" 0.63x, scanning stage 130x100 PIEZO, stage controller XY PIEZO WSB CAN, universal mounting frame K-M, AI sample finder f/Observer, Zen Toolkit for Bio Apps DLic, and software upgrade with motorized acquisition toolkit ZEN 3.10 DLic. The system must automate slide preparation and navigation using specialized cameras, darkfield composite contrast, and deep learning algorithms to reduce experiment setup times from minutes to seconds. A minimum one-year manufacturer's warranty is required. The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing; PSC is 6640, Laboratory Equipment and Supplies.

This is a firm fixed-price procurement with FOB Destination delivery. Payment terms are net 30 days after government acceptance, with invoicing through the Department of Treasury's Invoice Processing Platform. Prices must remain firm through September 30, 2026. Evaluation uses lowest-priced technically acceptable and responsible offeror basis; technical acceptability is evaluated first through descriptive materials, literature, and brochures demonstrating compliance with stated minimum technical requirements. Offerors must be registered and active in SAM.gov and provide a UEI. The contract incorporates Section 508 accessibility compliance and Buy American Act compliance requirements.